Still deciding between semaglutide and tirzepatide

[Juice-Chick]

Appreciate everyone chiming in on my introduction post earlier, genuinely useful reading through so many different journeys. Still torn between sema and tirz honestly. Based on everything read so far, both bring real results but carry noticeably different profiles, trying to work out which fits my particular situation better, a stubborn fat loss stall despite staying consistent with both training and eating. For anyone who's run either option, or both, what ultimately tipped things one direction for you? And once decided, did the outcome line up with what was expected going in? Genuinely grateful for any perspective, still very much learning the ropes here.

 

[maintaining_log]

Different topic I guess, but been on tirzepatide over a year now, 15mg, losing weight and getting close to my goal. Someone in another thread mentioned switching back to sema and noticing their inflammation drop. I've got PMR and RA, so inflammation's a constant part of my life, plus my calcium score runs high, something inflammation apparently drives too. Curious whether sema actually does more for inflammation than tirzepatide does.

 

[tryingtoprogress14]

Came across a solid write-up comparing the two major medications if that's worth exploring further.

 

[Matt Allen]

Honestly it varies a ton person to person. Lost 20 total, the first 10 on semaglutide over six months, switched to tirzepatide since sema felt slow with rougher side effects on my end. Finished the last 10 on tirz in just three months, way faster with fewer sides. Did end up needing more though, 6mg weekly, being on the smaller side myself at 5'3 and 115 lbs.

 

[pickle_holdsteady]

Tirzepatide's been a far better fit for me than semaglutide. The sema side left me with more side effects and barely any weight change.

 

[quirky-pecan9987]

Tirz, no contest. Tried both and tirz worked far better for my body. Sema left me feeling ill without any real weight loss to show for it. Your mileage may vary though.

 

[ghostnova5]

You're still working with a fairly small amount then. People coming over from semaglutide often only notice a real blunting effect once they hit the higher end of tirzepatide dosing.
What amount of Wegovy were you running before?

 

[SZWH]

There's real substance to that, with one caveat attached. Looking at the sole direct comparison study out there, the third compound pulled ahead, roughly 20% average body-weight reduction against about 14% for the second compound across 72 weeks. So broadly speaking, yes, it does tend to come out on top. But that average masks a huge spread between individuals, and the second compound clearly delivered for you without a single hiccup, which is a genuinely rare and valuable outcome. Given how cleanly you handled it, restarting either one is defensible, the third compound could edge you a little further ahead, but your personal reaction and tolerance outweighs whatever the study numbers say.

As for finding coverage without insurance, things have changed quite a bit this year. The most trustworthy cash-pay path these days runs straight through the drugmakers themselves, their own direct programs sell specific branded doses out of pocket for roughly two to three hundred monthly now, far steadier pricing than what used to be available. Worth checking those prices first before anything else.

(Not medical advice, given it's been roughly a year and a half, definitely worth clearing a restart with a prescriber first.)

 

[Leslie40]

I'm in Canada too, also paying entirely out of pocket, so I really relate to this. Just made the switch to tirzepatide myself after losing 54 pounds on semaglutide.

Were the roles reversed, semaglutide's where I'd begin. Nothing stops you from switching to tirzepatide later if results don't match what you want. This route runs cheaper and is probably more sustainable long-term. And if you eventually need something stronger medically, that option's always available. Might not even come to that though, plenty of people do really well on semaglutide, and honestly the only way to know is to give it a shot! Good luck!

 

[onpath_vibes]

Honestly a bit surprised semaglutide's still holding onto this much popularity. Given it's not any cheaper, works less well for weight loss, and brings more side effects compared to the third compound, it's genuinely hard to justify starting someone new on it over the alternative. It does have a longer track record on benefits outside weight loss, cardiovascular and kidney risk reduction especially, but everything coming out on the third compound so far strongly suggests this is a class-wide effect likely to hold true there too. Obviously if someone's already stable and doing well managing either condition, there's little reason to switch, but retaining existing patients isn't going to move the needle much for a company's bottom line either.

Unfortunate timing for one manufacturer, since a competitor simply developed stronger drugs, or got luckier along the way. The fifth compound underperformed as a standalone weight-loss option, and paired with sema it comes close to matching the third compound but with a rougher side effect profile, while both the oral version of the second compound and another oral competitor also fall short on effectiveness and tolerability compared to the third compound. The fifth compound does look promising layered onto reta or tirz at small amounts, but given the separate ownership situation, formal studies on that combination seem unlikely. The oral second compound never got much marketing push either and wasn't rolled out everywhere, so it clearly isn't